USD 0.04
(-34.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 2.71 Million USD | -34.59% |
2021 | 4.15 Million USD | -24.68% |
2020 | 5.51 Million USD | -5.53% |
2019 | 5.83 Million USD | 496.89% |
2018 | 977.78 Thousand USD | 71.82% |
2017 | 569.07 Thousand USD | 13.81% |
2016 | 500 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2023 Q3 | 776.75 Thousand USD | -28.1% |
2023 Q4 | - USD | -100.0% |
2023 FY | - USD | -100.0% |
2023 Q1 | 1.31 Million USD | -51.65% |
2023 Q2 | 1.08 Million USD | -17.74% |
2022 Q2 | 3.41 Million USD | -10.25% |
2022 FY | 2.71 Million USD | -34.59% |
2022 Q3 | 3.12 Million USD | -8.42% |
2022 Q1 | 3.8 Million USD | -8.5% |
2022 Q4 | 2.71 Million USD | -13.03% |
2021 Q3 | 4.08 Million USD | -8.9% |
2021 FY | 4.15 Million USD | -24.68% |
2021 Q1 | 3.72 Million USD | -32.43% |
2021 Q4 | 4.15 Million USD | 1.7% |
2021 Q2 | 4.48 Million USD | 20.31% |
2020 Q4 | 5.51 Million USD | -14.49% |
2020 Q2 | 4.77 Million USD | 17.16% |
2020 Q1 | 4.07 Million USD | -30.2% |
2020 FY | 5.51 Million USD | -5.53% |
2020 Q3 | 6.44 Million USD | 35.1% |
2019 Q3 | 6.51 Million USD | 5.72% |
2019 Q4 | 5.83 Million USD | -10.42% |
2019 Q2 | 6.16 Million USD | 46.14% |
2019 Q1 | 4.21 Million USD | 331.25% |
2019 FY | 5.83 Million USD | 496.89% |
2018 Q2 | 1.42 Million USD | 193.66% |
2018 FY | 977.78 Thousand USD | 71.82% |
2018 Q4 | 977.78 Thousand USD | -6.97% |
2018 Q3 | 1.05 Million USD | -26.2% |
2018 Q1 | 484.99 Thousand USD | -14.77% |
2017 Q4 | 569.07 Thousand USD | 0.0% |
2017 FY | 569.07 Thousand USD | 13.81% |
2016 FY | 500 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 1.34 Billion USD | 100.0% |
Addus HomeCare Corporation | 124.13 Million USD | 100.0% |
AirSculpt Technologies, Inc. | 69.5 Million USD | 100.0% |
Amedisys, Inc. | 346.76 Million USD | 100.0% |
American Oncology Network, Inc. | 120.44 Million USD | 100.0% |
Astrana Health, Inc. | 296.26 Million USD | 100.0% |
Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 100.0% |
biote Corp. | 106.63 Million USD | 100.0% |
Cryo-Cell International, Inc. | 9.28 Million USD | 100.0% |
Cross Country Healthcare, Inc. | 2.66 Million USD | 100.0% |
COMPASS Pathways plc | 28.75 Million USD | 100.0% |
DocGo Inc. | 15.16 Million USD | 100.0% |
The Ensign Group, Inc. | 1.78 Billion USD | 100.0% |
Healthcare Services Group, Inc. | 11.23 Million USD | 100.0% |
InnovAge Holding Corp. | 100.49 Million USD | 100.0% |
Assure Holdings Corp. | 505 Thousand USD | 100.0% |
The Joint Corp. | 2 Million USD | 100.0% |
LifeStance Health Group, Inc. | 280.28 Million USD | 100.0% |
Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | 100.0% |
ModivCare Inc. | 983.75 Million USD | 100.0% |
NewGenIvf Group Limited | 118.97 Thousand USD | 100.0% |
Novo Integrated Sciences, Inc. | 1.75 Million USD | 100.0% |
Option Care Health, Inc. | 1.05 Billion USD | 100.0% |
P3 Health Partners Inc. | 108.31 Million USD | 100.0% |
P3 Health Partners Inc. | 108.31 Million USD | 100.0% |
The Pennant Group, Inc. | 312.51 Million USD | 100.0% |
Surgery Partners, Inc. | 2.03 Billion USD | 100.0% |
Syra Health Corp. Class A Common Stock | - USD | NaN% |
Talkspace, Inc. | - USD | NaN% |
Talkspace, Inc. | - USD | NaN% |
The Oncology Institute, Inc. | 86.82 Million USD | 100.0% |
The Oncology Institute, Inc. | 86.82 Million USD | 100.0% |